Genetically modified mouse models in studies on cutaneous wound healing

Experimental Physiology

Volumn 85, Issue 6, 2000, Pages 687-704

  Scheid, Annette ^a,b   Meuli, Martin ^a   Gassmann, Max ^b   Wenger, Roland H ^c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; CYTOKINE; CYTOSKELETON PROTEIN; DNA; DNA BINDING PROTEIN; GROWTH FACTOR; NITRIC OXIDE SYNTHASE; PLASMINOGEN; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL GENETICS; ANIMAL MODEL; CONTROLLED STUDY; DNA MODIFICATION; GENE FUNCTION; GENE TECHNOLOGY; GENE TRANSFER; GENETIC ANALYSIS; GENETIC MANIPULATION; GENETIC MODEL; KNOCKOUT MOUSE; MEDICAL RESEARCH; MOUSE; NONHUMAN; REVIEW; SKIN INJURY; TRANSGENIC MOUSE; WOUND HEALING;

EID: 0033664951     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-445X.2000.02103.x     Document Type: Review

References (173)

1. Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice
2. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase
3. Functions of the POU domain genes Skn-la/i and Tst-l/Oct-6/SCIP in epidermal differentiation
4. CD44 is the principal cell surface receptor for hyaluronate
5. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
6. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
7. The Nfl tumor suppressor regulates mouse skin wound-healing, fibroblast proliferation, and collagen deposited by fibroblasts
8. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice
9. Midgestational lethality in mice lacking keratin 8
10. Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin
11. Platelet-derived growth factor: A key regulator of connective tissue cells in embryogenesis and pathogenesis
12. Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice
13. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
14. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions
15. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice
16. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
17. Perfect wound healing in the keratin 8 deficient mouse embryo
18. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
19. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
20. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
21. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
22. Impaired wound contraction in stromelysin-1-deficient mice
23. Stromelysin-1-deficient fibroblasts display impaired contraction in vitro
24. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
25. Physiological consequences of loss of plasminogen activator gene function in mice
26. Smad5 knockout mice die at midgestation due to multiple embryonic and extraembryonic defects
27. Re-epithelialization of normal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins
28. Role of the thrombin receptor in development and evidence for a second receptor
29. Mice lacking the thrombin receptor. PAR1, have normal skin wound healing
30. Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice
31. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis
32. STATs and gene regulation
33. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction
34. Synergistic activities of alpha3 and alpha6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse
35. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
36. Epidermal expression of collagenase delays wound-healing in transgenic mice
37. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
38. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas
39. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
40. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft
41. Gene therapy for tissue repair: Approaches and prospects
42. Particle-mediated gene transfer of PDGF isoforms promotes wound repair
43. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
44. Role of vascular endothelial growth factor in the regulation of angiogenesis
45. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
46. Skin wounds and severed nerves heal normally in mice lacking tenasein-C
47. Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice
48. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing
49. Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins
50. Tumor induction of VEGF promoter activity in stromal cells
51. Wound repair in the context of extracellular matrix
52. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
53. Desmosomes and hemidesmosomes
54. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin
55. Essential role of alpha 6 integrins in cortical and retinal lamination
56. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice
57. Mesodermal development in mouse embryos mutant for fibronectin
58. Cre-loxP-mediated inactivation of the alpha6A integrin splice variant in vivo: Evidence for a specific functional role of alpha6A in lymphocyte migration but not in heart development
59. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion
60. The role of apoptosis in wound healing
61. Gene targeting of BPAG1: Abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration
62. Keratinocyte growth factor is required for hair development but not for wound healing
63. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice
64. Overexpression of mouse follistatin causes reproductive defects in transgenic mice
65. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development
66. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system
67. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres
68. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
69. Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice
70. Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin
71. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
72. Skin abnormality in aged fyn-/-fak+/-mice
73. 2 homeostasis by hypoxia-inducible factor 1α
74. Tumour predisposition in mice heterozygous for a targeted mutation in Nfl
75. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
76. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier
77. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction
78. Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice
79. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation
80. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease
81. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice
82. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
83. Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity
84. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene
85. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis
86. Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins
87. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
88. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia
89. Essential role of mouse telomerase in highly proliferative organs
90. Impaired wound healing and angiogenesis in eNOS-deficient mice
91. Maternal rescue of transforming growth factor-beta 1 null mice
92. Altered wound healing in mice lacking a functional osteopontin gene
93. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing
94. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
95. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
96. Functional overlap between two classes of matrix-degrading proteases in wound healing
97. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine
98. Normal neutrophil function in cathepsin G-deficient mice
99. The tenascin-C knockout revisited
100. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
101. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
102. Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin
103. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation
104. Actin cables and epidermal movement in embryonic wound healing
105. Different phenotypes for mice deficient in either activins or activin' receptor type II
106. Functional analysis of activins during mammalian development
107. Multiple defects and perinatal death in mice deficient in follistatin
108. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice
109. Epithelial immaturiy and multiorgan failure in mice lacking epidermal growth factor receptor
110. Biology and biochemistry of proteinases in tumor invasion
111. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during development and injury-related tissue remodeling
112. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction
113. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair
114. Vascular endothelial growth factor (VEGF) and its receptors
115. Oxygen supply in healing tissue
116. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
117. Podokinesis in endothelial cell migration: Role of nitric oxide
118. Wound Healing in the gelsolin knockout mouse: Evidence that cytoskeletal factors are important in sear formation
119. Neuronal defects and delayed wound healing in mice lacking. Fibroblast growth factor 2
120. Bel-x expression influences keratinocyte cell survival but not terminal differentiation
121. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
122. Expression of thrombomodulin and consequences of thrombomodulin deficiency during healing of cutaneous wounds
123. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. Monocytogenes infection
124. Thrombospondin 1 knockout mice show delayed organization and prolonged neovascularization of skin wounds
125. Transforming growth factor-beta 3 is required for secondary palate fusion
126. Keratinocyte-specific expression of human thrombomodulin in transgenic mice: Effects on epidermal differentiation and cutaneous wound healing
127. Impaired wound healing in mice with a disrupted plasminogen gene
128. Plasminogen and wound healing
129. Longevity, stress response, and cancer in aging telomerase-deficient mice
130. Mice develop normally without tenascin
131. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions
132. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis
133. Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice
134. Role of elevated plasma transforming growth factor-beta 1 levels in wound healing
135. Elevated blood pressures in mice lacking endothelial nitric oxide synthase
136. Hepatocyte growth factor-like protein is identical to macrophage stimulating protein
137. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
138. Strain-dependent epithelial defects in mice lacking the EGF receptor
139. Mechanisms of disease - Cutaneous wound healing
140. Macrophage stimulating protein: Purification, partial amino acid sequence, and cellular activity
141. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
142. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells
143. Role of endothelial selectins in wound repair
144. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice
145. Transfection with aFGF cDNA improves wound healing
146. Prothrombin deficiency results in embryonic and neonatal lethality in mice
147. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
148. Increased vascularization in mice overexpressing angiopoietin-1
149. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
150. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
151. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps
152. Pathogenesis of cleft palate in TGF-beta3 knockout mice
153. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
154. The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice
155. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
156. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction
157. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation
158. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo
159. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta- mediated growth inhibition
160. Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis
161. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2
162. Mammalian oxygen sensing, signalling and gene regulation
163. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds
164. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin
165. Vinculin knockout results in heart and brain defects during embryonic development
166. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral mediated iNOS gene transfer
167. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta
168. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts
169. Vitronectin is not essential for normal mammalian development and fertility
170. Fibroblast growth factor 2 control of vascular tone
171. Smad3 mutant mice develop metastatic colorectal cancer
172. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis